{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:10Z","timestamp":1791478330512,"version":"4.3.4"},"reference-count":38,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>A clinical, biochemical, histological and molecular genetic analysis of 60 McArdle patients (33 males and 27 females; mean age at diagnosis: 37 years) was performed. The objective of this study was to identify a possible genotype\u2013phenotype correlation in McArdle disease. All patients complained of exercise-induced myalgia and fatigue; permanent weakness was present in 47% of the patients. Five percent of patients conveyed of masticatory muscle weakness. Age of onset was &lt;15 years in 92% patients. Serum creatine kinase was elevated 5 to13-fold. Forearm ischemic test showed decreased lactate production but excessively increased ammonia upon exercise (n = 16). Muscle biopsies revealed highly reduced or missing myophosphorylase activity (n = 20) (mean: 0.17 \u00b1 0.35 U\/g tissue; normal: 12\u201361) and histologically, sub-sarcolemmal glycogen accumulation (n = 9). Molecular genetic analysis revealed the common p.Arg50Ter mutation in 68% of the patients. Other rather frequent mutations were p.Arg270Ter (allele frequency: 5%) followed by c.2262delA and p.Met1Val (allele frequencies: 3%). Twenty-four other rare mutations were also identified. No genotype\u2013phenotype correlation was observed. The analysis highlights that testing of the p.Arg50Ter mutation could be performed first in molecular genetic testing of patients with exercise intolerance possibly due to McArdle disease. However, there is enormous mutation heterogeneity in McArdle disease thus sequencing of the myophosphorylase gene is needed in patients highly suspicious of McArdle disease.<\/jats:p>","DOI":"10.3390\/biomedicines8020033","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T10:10:25Z","timestamp":1582020625000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["McArdle Disease: Clinical, Biochemical, Histological and Molecular Genetic Analysis of 60 Patients"],"prefix":"10.3390","volume":"8","author":[{"given":"Pushpa Raj","family":"Joshi","sequence":"first","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Deschauer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"},{"name":"Department of Neurology, School of Medicine, Technical University Munich, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zierz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1566524024605770","article-title":"Myophosphorylase deficiency (glycogenosis type V.; McArdle disease)","volume":"2","author":"Dimauro","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00415-006-0447-x","article-title":"Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations","volume":"254","author":"Deschauer","year":"2007","journal-title":"J. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Santalla, A., Nogales-Gadea, G., Encinar, A.B., Vieitez, I., Gonz\u00e1lez-Quintana, A., Serrano-Lorenzo, P., Consuegra, I.G., Asensio, S., Ballester-Lopez, A., and Pintos-Morell, G. (2017). Genotypic and phenotypic features of all Spanish patients with McArdle disease: A 2016 update. BMC Genom., 18.","DOI":"10.1186\/s12864-017-4188-2"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.22806","article-title":"McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene","volume":"36","author":"Brull","year":"2015","journal-title":"Hum. Mutat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM199307223290404","article-title":"Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle\u2019s disease)","volume":"329","author":"Tsujino","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1529-8817.2003.00067.x","article-title":"Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle\u2019s disease","volume":"68","author":"Rubio","year":"2004","journal-title":"Ann. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0022-510X(95)00298-G","article-title":"Molecular characterization of myophosphorylase deficiency in a group of patients from northern Italy","volume":"137","author":"Martinuzzi","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T","article-title":"Human gene mutation database-a biomedical information and research resource","volume":"15","author":"Krawczak","year":"2000","journal-title":"Hum. Mutat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","article-title":"McArdle disease: A clinical review","volume":"81","author":"Quinlivan","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/gim.2015.9","article-title":"Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data","volume":"17","author":"Johnston","year":"2015","journal-title":"Genet. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","article-title":"Genotypic and phenotypic features of McArdle disease: Insights from the Spanish national registry","volume":"83","author":"Lucia","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/humu.9434","article-title":"McArdle disease: The mutation spectrum of PYGM in a large Italian cohort","volume":"27","author":"Bruno","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.nmd.2011.07.002","article-title":"Molecular and clinical study of McArdle\u2019s disease in a cohort of 123 European patients. Identification of 20 novel mutations","volume":"21","author":"Vieitez","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"ref_14","first-page":"545","article-title":"Lactate and pyruvate blood levels in the diagnosis of mitochondrial myopathies","volume":"60","author":"Zierz","year":"1989","journal-title":"Nervenarzt"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00415-006-0101-7","article-title":"Lactate production upon short-term non-ischemic forearm exercise in mitochondrial disorders and other myopathies","volume":"253","author":"Hanisch","year":"2006","journal-title":"J. Neurol."},{"key":"ref_16","unstructured":"Bergmeyer, H.U. (1974). Phosphorylase a. Methods of Enzymatic Analysis, Elsevier."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1113\/JP270085","article-title":"Phenotype consequences of myophosphorylase dysfunction: Insights from the McArdle mouse model","volume":"593","author":"Brull","year":"2015","journal-title":"J. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wokke, J.H.J., van Doorn, P.A., Hoogendijk, J.E., and de Visser, M. (2013). Neuromuscular Disease: A Case-Based Approach, Cambridge University Press.","DOI":"10.1017\/CBO9780511735905"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1098-1004(1998)12:1<27::AID-HUMU4>3.0.CO;2-#","article-title":"Molecular diagnosis of McArdle disease: Revised genomic structure of the myophosphorylase gene and identification of a novel mutation","volume":"12","author":"Kubisch","year":"1998","journal-title":"Hum. Mutat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.1225","article-title":"Molecular heterogeneity of myophosphorylase deficiency (McArdle\u2019s disease): A genotype-phenotype correlation study","volume":"50","author":"Rubio","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_21","unstructured":"Engel, A.G., and Franzini-Armstrong, C. (1994). Nonlysosomal glycogenoses. Myology, McGraw-Hill. [2nd ed.]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.21351","article-title":"Permanent muscle weakness in McArdle disease","volume":"40","author":"Vincitorio","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2006.04.017","article-title":"Muscle pain in myophosphorylase deficiency (McArdle\u2019s disease): The role of gender, genotype, and pain-related coping","volume":"124","author":"Rommel","year":"2006","journal-title":"Pain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2018.11.023","article-title":"Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: A questionnaire-based survey","volume":"59","author":"Joshi","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mus.24716","article-title":"Minimally symptomatic Mcardle disease, expanding the genotype-phenotype spectrum: Minimally Symptomatic McArdle Disease","volume":"52","author":"Petrou","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2005.03.002","article-title":"A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease","volume":"85","author":"Isackson","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/practneurol-2014-001031","article-title":"Serum CK as a guide to the diagnosis of muscle disease","volume":"15","author":"Renard","year":"2015","journal-title":"Pract. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/BF01711182","article-title":"Increased ammonia production during forearm ischemic work test in McArdle\u2019s disease","volume":"59","author":"Rumpf","year":"1981","journal-title":"Klin. Wochenschr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI112006","article-title":"Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII","volume":"76","author":"Mineo","year":"1985","journal-title":"J. Clin. Invest."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/mus.880090305","article-title":"The ischemic exercise test in normal adults and in patients with weakness and cramps","volume":"9","author":"Coleman","year":"1986","journal-title":"Muscle Nerve"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.10263","article-title":"A nonischemic forearm exercise test for McArdle disease","volume":"52","author":"Skomorowska","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/01616412.2016.1243638","article-title":"Normal activities of AMP-deaminase and adenylate kinase in patients with McArdle disease","volume":"38","author":"Joshi","year":"2016","journal-title":"Neurol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/01.wnl.0000230154.79933.d7","article-title":"Do carriers of PYGM mutations have symptoms of McArdle disease?","volume":"67","author":"Andersen","year":"2006","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/hmg\/2.8.1291","article-title":"McArdle\u2019s disease: A nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases","volume":"2","author":"Bartram","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12017-013-8233-2","article-title":"Clinical and molecular characterization of McArdle\u2019s disease in Brazilian patients","volume":"15","author":"Bellard","year":"2013","journal-title":"Neuromolecular Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0009-8981(95)06044-X","article-title":"Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle\u2019s disease): Single-codon deletion in exon 17 is the predominant mutation","volume":"236","author":"Sugie","year":"1995","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","article-title":"Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease","volume":"132","author":"Vissing","year":"2009","journal-title":"Brain J. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/humu.23591","article-title":"Missense mutations have unexpected consequences: The McArdle disease paradigm","volume":"39","author":"Pinos","year":"2018","journal-title":"Hum. Mutat."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/2\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:58:03Z","timestamp":1760173083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/2\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["biomedicines8020033"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8020033","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]}}}